In this exclusive interview Tobias Noeske, Associate Principal Scientist from AstraZeneca, speaks to Andrea Charles from Pharma IQ, about the recent trends in computational toxicology and critical success factors for transporter studies in drug applications. Noeske also discusses key findings on relationship between BSEP inhibition and molecular physicochemical properties, and why it is important for drugs not to inhibit the bile salt export protein.
Trends in Computational Toxicology & Critical Success Factors for Transporter Studies- Full Interview with Tobias Noeske
Pharmaceuticals & Biotechnology Editor | 06/27/2013